GNRHR and endometrial carcinoma: The gonadotropin-releasing hormone (GnRH) receptor was found to be overexpressed in a variety of cancer cells, including melanoma, prostate, and endometrial carcinomas, leiomyomas, breast cancer, choriocarcinoma, and ovarian tumors [72,73,74].